Feili Gong

Feili Gong

Auto-generated profile, based on publicly available information

Feili Gong

Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
FZFanfan Zeng
Fanfan Zeng
HCHuoying Chen
Huoying Chen
LCLan Chen
Lan Chen
JMJie Mao
Jie Mao
SCShaozhe Cai
Shaozhe Cai
FZFang Zheng
Fang Zheng

1 May 2018 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SHShunmei Huang
Shunmei Huang
SZShi Zou
Shi Zou
MCMingfa Chen
Mingfa Chen
XGXiaoyan Gao
Xiaoyan Gao
LCLiwen Chen
Liwen Chen
JWJun Wu
Jun Wu
Functional maturation of liver sinusoidal endothelial cells (LSECs) induced by a NOD1 ligand (diaminopimelic acid [DAP]) during viral infection has not been well defined. Thus, we investigated the role of DAP-stimulated LSEC maturation during hepatitis B virus (HBV) infection and its potential mechanism in a hydrodynamic injection (HI) mouse model. Primary LSECs were isolated from wild-type C57BL/6 mice and stimulated with DAP in vitro and in vivo and assessed for the expression of surface markers as well as for their ability to promote T cell responses via flow cytometry. The effects of LSEC maturation on HBV replication and expression and the role of LSECs in the regulation of other immune cells were also investigated. Pretreatment of LSECs with DAP induced T cell activation in vitro. HI-administered DAP induced LSEC maturation and subsequently enhanced T cell responses, which was accompanied by an increased production of intrahepatic cytokines, chemokines, and T cell markers in the liver. The HI of DAP significantly reduced the HBsAg and HBV DNA levels in the mice. Importantly, the DAP-induced anti-HBV effect was impaired in the LSEC-depleted mice, which indicated that LSEC activation and T cell recruitment into the liver were essential for the antiviral function mediated by DAP application. Taken together, the results showed that the Ag-presenting ability of LSECs was enhanced by DAP application, which resulted in enhanced T cell responses and inhibited HBV replication in a mouse model.

1 February 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YZYuanyue Zhang
Yuanyue Zhang
LLLingyun Li
Lingyun Li
CQChang Qi
Chang Qi
SHShuyao Hua
Shuyao Hua
XFXiaoyuan Fei
Xiaoyuan Fei
MFMin Fang
Min Fang
Glycyrrhizin, a triterpenoid compound, has been reported to be an anti-inflammatory agent for the treatment of a variety of inflammatory diseases including hepatitis. However, the mechanism by which glycyrrhizin inhibits inflammation is unclear. Using a Con A-induced hepatitis model in mice, we found that administration of glycyrrhizin ameliorates Con A-induced liver injury, which manifests as reduction in the production of inflammatory cytokines IFN-γ, IL-6 and IL-17, as well as serum alanine aminotransferase (ALT). Blockade of IL-17 dramatically mitigates liver injury resulting from Con A challenge. Interestingly, at both the mRNA and protein levels, the endogenous alarmin inflammatory molecule high-mobility group box 1 (HMGB1) is significantly decreased in mice injected with glycyrrhizin combined with Con A compared to those injected with Con A alone. In contrast, the administration of glycyrrhizin with Con A challenge up-regulates the production of IL-25. Furthermore, an increase in the proportion of protective lymphocyte subset, Gr-1+ CD11b+ (Myeloid-Derived Suppressor Cell, MDSCs), could be induced by increased IL-25 to restrain immune cell activation and favor the resolution of detrimental immune reactions caused by Con A challenge. The results indicate that glycyrrhizin plays a protective role in Con A-induced hepatitis. This protective role is particularly associated with reducing the production of IL-17 and enhancing the expression of IL-25. The present study may provide a new strategy for the treatment of acute hepatitis in the clinical setting.

13 June 2022 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
JSJunyu Shi
Junyu Shi
YXYifan Xiao
Yifan Xiao
NZNa Zhang
Na Zhang
MJMengya Jiao
Mengya Jiao
XTXuhuan Tang
Xuhuan Tang
FZFang Zheng
Fang Zheng

1 April 2009 in Pancreas
Verified
Journal Article
Closed access
CCCaihong Chang
Caihong Chang
XWXinjun Wang
Xinjun Wang
DNDeliang Niu
Deliang Niu
ZZZhan Zhang
Zhan Zhang
HZHongyang Zhao
Hongyang Zhao
FGFeili Gong
Feili Gong
This study observed whether mesenchymal stem cells (MSCs) adopt β-cell fate upon diabetic microenvironment. We transplanted male porcine MSCs to diabetic female pigs by directly injecting into pancreas. Recipients' sera and pancreatic tissue were analyzed to assess the therapeutic effect. Islets were collected from the sections using laser-capture microdissection. The RNAs from these specimens were extracted and analyzed for insulin and pancreas duodenum homeobox 1 messenger RNA (mRNA) expression. SRY gene was detected from the specimens. Compared with untreated diabetic controls, blood glucose level decreased greatly in recipients from 18 days (15.44 ± 0.31 mmol/L vs 16.66 ± 0.11 mmol/L) and insulin increased from 14 days (0.048 ± 0.006 U/L vs 0.030 ± 0.004 U/L). Hematoxylin and eosin-stained sections demonstrated increased islets in recipients and few lymphocytes present. The newly formed islets were smaller than normal islets (47.2 μm ± 19.6 vs 119.6 ± 27.7 μm). Reverse transcription-polymerase chain reaction showed that microdissected cells expressed insulin and pancreas duodenum homeobox 1 mRNA (79.3% ± 16.2% of control, 65.2% ± 14.8% of control, respectively). Immunoreactivity showed that the transplanted MSCs expressed insulin. SRY gene and insulin mRNA double-positive cells were found in microdissected cells by fluorescence in situ hybridization. This study shows that MSCs could adopt β-cell fate in diabetic pancreatic microenvironment without obvious immune rejections. Stem cell transplantation in orthotope is a promising therapy for diabetes.